Table 3.
Scaffolds | Gene | Vector | Implantation | Time | Ref | |
---|---|---|---|---|---|---|
Hydrogel | PEG hydrogel scaffolds | siRNA | PEI | In vitro | 4 weeks | 87 |
Injectable CPC augmentation matrix scaffolds | siRNA-RANK | PLGA microparticles | In vitro | 12 days | 132 | |
DEX hydrogel scaffolds | siRNA-GFP | PEI | In vitro | 17 days | 139 | |
Dual-crosslinked photodegradable hydrogels scaffolds | siRNA-Noggin | PEI | In vitro | 2 weeks | 140 | |
Fibrin hydrogel scaffolds | siRNA-Noggin | Lipofectamine 2000 | In vitro | 48 hours | 141 | |
PEG hydrogel scaffolds | siRNA-Noggin | PEI | Calvarial bone defect model in rats | 12 weeks | 13 | |
SFCS scaffolds | siRNA-GNAS1 siRNA-PHD2 |
siPort amine transfection agent | Subcutaneous transplantation for ectopic bone formation | 10 weeks | 130 | |
PLA-DX-PEG pellet | siRNA-Noggin | PLA-DX-PEG polymer | The left dorsal muscle pouches of mouse for ectopic bone formation | 7 days | 142 | |
PLGA-PEG-PLA-DM hydrogel scaffolds | siRNA-Cy5 | Polymer diblock NPs | Femur fracture model | 4 weeks | 143 | |
PLLA scaffolds | siRNA-Sema4d | Asp8-Stearyl-R8 | Femoral defect model in OVX rats | 8 weeks | 144 | |
Collagen | Collagen sponge disk scaffolds | siRNA-Noggin | Lipofectamine 2000 (in vitro) Electroporation (in vivo) | Dorsal muscular tissue in the Male ICR mice for ectopic bone induction | 2 weeks | 12 |
CS | CS sponge scaffolds | siRNA-Ckip-1 and siRNA-Flt-1 | Lipofectamine™ 2000 | Calvarial bone defect model in rats | 12 weeks | 124 |
Abbreviations: Ckip-1: casein kinase 2 interaction protein 1; CPC: calcium phosphatecement; DEX: dextran; Flt-1: soluble VEGF receptor 1; GFP: green fluorescent protein; GNAS1: guanine nucleotide-binding protein alpha subunit 1; PEG-PLA-DM : poly(ethylene glycol)-poly(lactic acid)-dimethacrylate; PEI: polyetherimide; PHD2: prolyl hydroxylase domaincontaining protein 2; PLA-DX-PEG: poly-D,L-lactic acid-p-dioxanonepolyethylene glycol block co-polymer; PLLA: poly-L-lactic acid; SFCS: silk fibroin-chitosan.